JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lal, A. B.
Right arrow Articles by Scott, N. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lal, A. B.
Right arrow Articles by Scott, N. B.
Related Collections
Right arrow Cardiovascular
Right arrow Heart
Right arrow Pediatrics

Anesth Analg 2005;101:1628-1630
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000184186.95127.E2

PEDIATRIC ANESTHESIA

Aortic Valve Repair in a Patient with Congenital Afibrinogenemia

Adarsh B. Lal, FFARCSI, Ram Maruthavanan, MRCP, and Nicholas B. Scott, FRCS(Ed), FFARCSI

Golden Jubilee National Hospital, Clydebank, United Kingdom

Address correspondence and reprint requests to Adarsh B. Lal, Consultant Anesthetist, Golden Jubilee National Hospital, Beardmore St., Clydebank G81 4HX, United Kingdom. Address e-mail to adarsh.lal{at}gjnh.scot.nhs.uk.

We describe the management of cardiopulmonary bypass (CPB) in a patient with congenital afibrinogenemia (AF). Although this state is akin to the state after hirudin administration, where CPB has been successfully performed, heparinization is still essential to preserve other clotting factors and prevent excessive bleeding. Aprotinin further helps in preservation of clotting factors. There are case reports of thrombosis associated with AF, but aprotinin can be safely used because it is, by definition, an anticoagulant. Cryoprecipitate effectively restores the fibrinogen and produces normal clotting.






Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.